Cargando…

An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching

Although TGF-β signaling can effectively activate fibroblasts to transform to myofibroblasts, the underlying mechanisms involved in the cell fate switching for trans-differentiation have not been fully elucidated. In this study, we found the evidence of an intermediate state in the process of trans-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zhikai, Li, Wenbo, Jiang, Zhenlong, Wang, Erkang, Wang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441076/
https://www.ncbi.nlm.nih.gov/pubmed/34541470
http://dx.doi.org/10.1016/j.isci.2021.103057
_version_ 1783752802487500800
author Ye, Zhikai
Li, Wenbo
Jiang, Zhenlong
Wang, Erkang
Wang, Jin
author_facet Ye, Zhikai
Li, Wenbo
Jiang, Zhenlong
Wang, Erkang
Wang, Jin
author_sort Ye, Zhikai
collection PubMed
description Although TGF-β signaling can effectively activate fibroblasts to transform to myofibroblasts, the underlying mechanisms involved in the cell fate switching for trans-differentiation have not been fully elucidated. In this study, we found the evidence of an intermediate state in the process of trans-differentiation. In the early stage of trans-differentiation, cells enter the intermediate state first with multiple characteristics such as accelerating cell cycle, metabolic switching, enhanced anti-apoptotic ability, and pluripotency, which is very similar to the early stage of reprogramming. As the trans-differentiation continues, these characteristics get switched. Therefore, trans-differentiation appears to require the switching of cell proliferation ability, metabolic pathway, and “stemness” to complete the process. In this study, we can conclude that an intermediate state may be necessary with high pluripotency in trans-differentiation from fibroblasts to myofibroblasts. Only after passing the intermediate state, the trans-differentiation is finally completed and will not easily return to the original state.
format Online
Article
Text
id pubmed-8441076
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84410762021-09-17 An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching Ye, Zhikai Li, Wenbo Jiang, Zhenlong Wang, Erkang Wang, Jin iScience Article Although TGF-β signaling can effectively activate fibroblasts to transform to myofibroblasts, the underlying mechanisms involved in the cell fate switching for trans-differentiation have not been fully elucidated. In this study, we found the evidence of an intermediate state in the process of trans-differentiation. In the early stage of trans-differentiation, cells enter the intermediate state first with multiple characteristics such as accelerating cell cycle, metabolic switching, enhanced anti-apoptotic ability, and pluripotency, which is very similar to the early stage of reprogramming. As the trans-differentiation continues, these characteristics get switched. Therefore, trans-differentiation appears to require the switching of cell proliferation ability, metabolic pathway, and “stemness” to complete the process. In this study, we can conclude that an intermediate state may be necessary with high pluripotency in trans-differentiation from fibroblasts to myofibroblasts. Only after passing the intermediate state, the trans-differentiation is finally completed and will not easily return to the original state. Elsevier 2021-08-28 /pmc/articles/PMC8441076/ /pubmed/34541470 http://dx.doi.org/10.1016/j.isci.2021.103057 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ye, Zhikai
Li, Wenbo
Jiang, Zhenlong
Wang, Erkang
Wang, Jin
An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching
title An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching
title_full An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching
title_fullStr An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching
title_full_unstemmed An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching
title_short An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching
title_sort intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441076/
https://www.ncbi.nlm.nih.gov/pubmed/34541470
http://dx.doi.org/10.1016/j.isci.2021.103057
work_keys_str_mv AT yezhikai anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT liwenbo anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT jiangzhenlong anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT wangerkang anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT wangjin anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT yezhikai intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT liwenbo intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT jiangzhenlong intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT wangerkang intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching
AT wangjin intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching